+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nisin Market by Type, Application: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 270 Pages
  • July 2021
  • Region: Global
  • Allied Market Research
  • ID: 5439875
The global nisin market was valued at $317.9 million in 2020, and is expected to garner $638.1 million by 2030, registering a CAGR of 7.3% from 2021 to 2030.



Nisin is a mixture of closely related antimicrobial polypepties, produced by strains of lactococcus lactis subspecies. Lactis can be digested into amino acids by a-chymotrypsin in human intestines and stomach. Nisin is used as natural food preservatives and can greatly decrease the required temperature, shortening the time in food processing. It also improves the nutritional value, appearance, flavor, and texture of foods and significantly prolong the shelf-life. Nisin has 34 amino acid residues, including the uncommon amino acids didehydroalanine, methyllanthionine, lanthionine, and didehydroaminobutyric acid.

Natural preservatives are naturally derived additives, which are used in a wide range of products, such as snacks, bakery, confectionery, meat, seafood, poultry, and others, to preserve the natural characteristics of food and increase their shelf life for storage. In addition, natural food preservatives are used to avoid spoilage during transportation. The traditional natural ways of preservation include freezing, boiling, smoking, pasteurizing, pickling, and others. Sugar and salt are the earliest natural ways of food preservation that efficiently reduce the growth of bacteria in food.

Change in consumer preferences is expected to be a major factor that surges the demand for nisin. Increase in demand for convenience products has increased the demand for foods with longer shelf life, thus augmenting the demand for nisin. Rise in consumption of ready-to-eat food products has also driven the consumption of natural preservatives in the recent past.

The market is segmented on the basis of type, application, and region. By type, it is divided into powder and liquid. On the basis of application, the market is split into food & beverages, pharmaceuticals, and cosmetics and personal care. The food & beverages segment is sub-segmented into meat and poultry products, dairy products, beverages, canned products, and others. The market is analyzed across four regions such as North America, Europe, Asia-Pacific, and LAMEA.

The prominent players in the global nisin market have strategically focused on product launch as their key strategy to gain significant share in the market. The key players in the market have utilized partnerships and acquisitions to stay relevant in the global market. The key players operating in the global nisin market are Cayman Chemical Company, Chihon Biotechnology Co., Ltd., Duke Thomson's India Pvt. Ltd., DuPont de Nemours, Inc., Galactic, Mayasan Biotech, Merck Group, Royal DSM, Santa Cruz Biotechnology, Inc., and Siveele B.V.

Key market benefits for stakeholders

  • The report provides extensive analysis of the current & emerging trends and opportunities in the Nisin market.
  • Current and future trends are outlined in the report to determine the overall market attractiveness and single out profitable trends to gain a stronger foothold in the market.
  • The report provides information regarding drivers, restraints, and opportunities with impact analysis.
  • Quantitative analysis of the current market and estimation for the same from 2020 to 2028 is provided to showcase the financial competency of the market
  • Porter’s five forces model of the industry demonstrates the competitiveness of the market by analyzing various parameters such as threat of new entrants, threat of substitutes, bargaining power of buyers, and bargaining power of suppliers operating in the market
  • Competitive intelligence highlights the business practices followed by the leading market players across various regions

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Key benefits for stakeholders
1.2. Key market segments
1.3. Research methodology
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.1.1. Global Nisin Market: Segmentation
3.2. Key findings
3.2.1. Top investment pockets
3.3. Parent Market
3.4. Top players positioning
3.5. Value chain analysis
3.6. Porter’s five forces analysis
3.6.1. Moderate bargaining power of suppliers
3.6.2. High bargaining power of buyers
3.6.3. Moderate threat of substitution
3.6.4. Moderate threat of new entrants
3.6.5. High Intensity of competitive rivalry
3.7. Market dynamics
3.7.1. Drivers
3.7.1.1. Growth in food and beverage industry
3.7.1.2. Shift of consumer preference towards ready-to-eat food products
3.7.1.3. Health hazards related to chemical preservatives
3.7.2. Restraints
3.7.2.1. Increase in demand for zero preservatives food products
3.7.3. Opportunities
3.7.3.1. Emerging markets in Asia-Pacific and LAMEA
3.8. Market share analysis
3.8.1. By type
3.8.2. By application
3.8.3. By region
3.10. Impact of COVID-19 on the Nisin market

CHAPTER 4: NISIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Powder
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Liquid
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: NISIN MARKET, APPLICATION
5.1. Overview
5.2. Market size and forecast
5.3. Food & Beverages
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Meat and Poultry Products
5.3.3.1. Key market trends, growth factors, and opportunities
5.3.4. Dairy Products
5.3.4.1. Key market trends, growth factors, and opportunities
5.3.5. Beverages
5.3.5.1. Key market trends, growth factors, and opportunities
5.3.6. Canned Products
5.3.6.1. Key market trends, growth factors, and opportunities
5.3.7. Others
5.3.7.1. Key market trends, growth factors, and opportunities
5.3.8. Market analysis, by country
5.4. Pharmaceuticals
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.5. Cosmetics and Personal care
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market analysis, by country

CHAPTER 6: NISIN MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast, by region
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U. S.
6.2.4.1.1. Market size and forecast, by Type
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Type
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Type
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Type
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Type
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Type
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Type
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Type
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Russia
6.3.4.6.1. Market size and forecast, by Type
6.3.4.6.2. Market size and forecast, by Application
6.3.4.7. Rest of Europe
6.3.4.7.1. Market size and forecast, by Type
6.3.4.7.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Type
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Market size and forecast, by Type
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Type
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. Australia
6.4.4.4.1. Market size and forecast, by Type
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. South Korea
6.4.4.5.1. Market size and forecast, by Type
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Indonesia
6.4.4.6.1. Market size and forecast, by Type
6.4.4.6.2. Market size and forecast, by Application
6.4.4.7. Srilanka
6.4.4.7.1. Market size and forecast, by Type
6.4.4.7.2. Market size and forecast, by Application
6.4.4.8. Rest of Asia-Pacific
6.4.4.8.1. Market size and forecast, by Type
6.4.4.8.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Type
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. Argentina
6.5.4.2.1. Market size and forecast, by Type
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. United Emirates Arab
6.5.4.3.1. Market size and forecast, by Type
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. Nigeria
6.5.4.4.1. Market size and forecast, by Type
6.5.4.4.2. Market size and forecast, by Application
6.5.4.5. Turkey
6.5.4.5.1. Market size and forecast, by Type
6.5.4.5.2. Market size and forecast, by Application
6.5.4.6. South Africa
6.5.4.6.1. Market size and forecast, by Type
6.5.4.6.2. Market size and forecast, by Application
6.5.4.7. Rest of LAMEA
6.5.4.7.1. Market size and forecast, by Type
6.5.4.7.2. Market size and forecast, by Application

CHAPTER 7: COMPETITION LANDSCAPE
7.1. Top winning strategies
7.2. Product mapping
7.3. Competitive dashboard
7.4. Competitive heat map
7.5. Key developments
7.5.1. Acquisition
7.5.2. Business Expansion
7.5.3. Product Launch

CHAPTER 8: COMPANY PROFILES
8.1. Cayman Chemical Company
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. Chihon Biotechnology Co., Ltd.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Product portfolio
8.3. Duke Thomson's India Pvt. Ltd.
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Product portfolio
8.4. DuPont de Nemours, Inc.,
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. R&D Expenditure
8.4.7. Business performance
8.4.8. Key strategic moves and developments
8.5. Galactic
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. Mayasan Biotech
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Product portfolio
8.7. Merck Group
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. R&D Expenditure
8.7.7. Business performance
8.7.8. Key strategic moves and developments
8.8. Royal DSM
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. R&D Expenditure
8.8.7. Business performance
8.8.8. Key strategic moves and developments
8.9. Santa Cruz Biotechnology, Inc.
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Product portfolio
8.10. Siveele B. V.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Product portfolio
8.10.5. Key strategic moves and developmentsLIST OF TABLES
TABLE 01. GLOBAL NISIN MARKET REVENUE, BY TYPE, 2021-2030 ($MILLION)
TABLE 02. NISIN MARKET REVENUE FOR POWDER, BY REGION, 2021-2030 ($MILLION)
TABLE 03. NISIN MARKET FOR LIQUID, BY REGION 2020-2030 ($MILLION)
TABLE 04. GLOBAL NISIN MARKET REVENUE, BY APPLICATION, 2021-2030($MILLION)
TABLE 05. NISIN MARKET REVENUE FOR FOOD & BEVERAGES, BY REGION, 2020-2030 ($MILLION)
TABLE 06. NISIN MARKET REVENUE FOR PHARMACEUTICALS, BY REGION, 2020-2030 ($MILLION)
TABLE 07. NISIN MARKET REVENUE FOR COSMETICS AND PERSONAL CARE, BY REGION, 2020-2030 ($MILLION)
TABLE 08. NISIN MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 09. NORTH AMERICA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 10. NORTH AMERICA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 11. NORTH AMERICA NISIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12. U.S. NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 13. U.S. NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 14. CANADA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 15. CANADA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16. MEXICO NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 17. MEXICO NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 18. EUROPE NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 19. EUROPE NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20. EUROPE NISIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21. GERMANY NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 22. GERMANY NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 23. FRANCE NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24. FRANCE NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 25. UK NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 26. UK NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 27. ITALY NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 28. ITALY NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 29. SPAIN NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 30. SPAIN NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 31. RUSSIA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 32. RUSSIA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33. REST OF EUROPE NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 34. REST OF EUROPE NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 35. ASIA-PACIFIC NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 36. ASIA-PACIFIC NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 37. ASIA-PACIFIC NISIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 38. CHINA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 39. CHINA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 40. JAPAN NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 41. JAPAN NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42. INDIA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43. INDIA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 44. AUSTRALIA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 45. AUSTRALIA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 46. SOUTH KOREA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 47. SOUTH KOREA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48. INDONESIA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 49. INDONESIA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 50. SRI LANKA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 51. SRI LANKA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52. REST OF ASIA-PACIFIC NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 53. REST OF ASIA-PACIFIC NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 54. LAMEA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 55. LAMEA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 56. LAMEA NISIN MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 57. BRAZIL NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 58. BRAZIL NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 59. ARGENTINA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 60. ARGENTINA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 61. UNITED EMIRATES ARAB NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 62. UNITED EMIRATES ARAB NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 63. NIGERIA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 64. NIGERA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 65. TURKEY NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 66. TURKEY NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 67. SOUTH AFRICA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. SOUTH AFRICA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 69. REST OF LAMEA NISIN MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 70. REST OF LAMEA NISIN MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 71. CAYMAN CHEMICAL COMPANY: KEY EXECUTIVES
TABLE 72. CAYMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 73. CAYMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
TABLE 74. CHIHON BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES
TABLE 75. CHIHON BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 76. CHIHON BIOTECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
TABLE 77. DUKE THOMSON'S INDIA PVT. LTD.: KEY EXECUTIVES
TABLE 78. DUKE THOMSON'S INDIA PVT. LTD.: COMPANY SNAPSHOT
TABLE 79. DUKE THOMSON'S INDIA PVT. LTD.: PRODUCT PORTFOLIO
TABLE 80. DUPONT DE NEMOURS, INC.,: KEY EXECUTIVES
TABLE 81. DUPONT DE NEMOURS, INC.,: COMPANY SNAPSHOT
TABLE 82. DUPONT DE NEMOURS, INC.,: OPERATING SEGMENTS
TABLE 83. DUPONT DE NEMOURS, INC.,: PRODUCT PORTFOLIO
TABLE 84. DUPONT DE NEMOURS, INC.,: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 85. DUPONT DE NEMOURS, INC.,: NET SALES, 2018-2020 ($MILLION)
TABLE 86. GALACTIC S. A.: KEY EXECUTIVES
TABLE 87. GALACTIC S. A.: COMPANY SNAPSHOT
TABLE 88. GALACTIC S. A.: PRODUCT PORTFOLIO
TABLE 89. MAYASAN BIOTECH: KEY EXECUTIVES
TABLE 90. MAYASAN BIOTECH: COMPANY SNAPSHOT
TABLE 91. MAYASAN BIOTECH: PRODUCT PORTFOLIO
TABLE 92. MERCK GROUP: KEY EXECUTIVES
TABLE 93. MERCK GROUP: COMPANY SNAPSHOT
TABLE 94. MERCK GROUP: OPERATING SEGMENTS
TABLE 95. MERCK GROUP: PRODUCT PORTFOLIO
TABLE 96. MERCK GROUP: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 97. MERCK GROUP: NET SALES, 2018-2020 ($MILLION)
TABLE 98. ROYAL DSM: KEY EXECUTIVES
TABLE 99. ROYAL DSM: COMPANY SNAPSHOT
TABLE 100. ROYAL DSM: OPERATING SEGMENTS
TABLE 101. ROYAL DSM: PRODUCT PORTFOLIO
TABLE 102. ROYAL DSM.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 103. ROYAL DSM: NET SALES, 2018-2020 ($MILLION)
TABLE 104. SANTA CRUZ BIOTECHNOLOGY, INC.: KEY EXECUTIVES
TABLE 105. SANTA CRUZ BIOTECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 106. SANTA CRUZ BIOTECHNOLOGY, INC.: PRODUCT PORTFOLIO
TABLE 107. SIVEELE B. V.: KEY EXECUTIVES
TABLE 108. SIVEELE B. V.: COMPANY SNAPSHOT
TABLE 109. SIVEELE B. V.: PRODUCT PORTFOLIOLIST OF FIGURES
FIGURE 01. GLOBAL NISIN MARKET SNAPSHOT
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. PARENT MARKET
FIGURE 04. VALUE CHAIN ANALYSIS
FIGURE 05. NISIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 06. NISIN MARKET REVENUE, BY TYPE, 2021-2030 ($MILLION)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF NISINKS MARKET FOR POWDER, BY COUNTRY, 2020 & 2030(%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS FOR NISIN MARKET FOR LIQUID, BY COUNTRY, 2020 & 2030(%)
FIGURE 09. NISIN MARKET, BY APPLICATION, 2020-2030
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF NISIN MARKET FOR FOOD & BEVERAGES, BY COUNTRY, 2020 & 2030(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NISIN MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020 & 2030 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NISIN MARKET FOR COSMETICS AND PERSONAL CARE, BY COUNTRY, 2020 & 2030(%)
FIGURE 13. NISIN MARKET, BY REGION, 2020 (%)
FIGURE 14. U.S. NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 15. CANADA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 16. MEXICO NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 17. GERMANY NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 18. FRANCE NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 19. UK NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 20. ITALY NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 21. SPAIN NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 22. RUSSIA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 23. REST OF EUROPE NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 24. CHINA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 25. JAPAN NISN MARKET, 2020-2030 ($MILLION)
FIGURE 26. INDIA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 27. AUSTRALIA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 28. SOUTH KOREA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 29. INDONESIA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 30. SRILANKA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 31. REST OF ASIA-PACIFIC NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 32. BRAZIL NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 33. ARGENTINA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 34. UNITED EMIRATES ARAB NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 35. NIGERIA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 36. TURKEY NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 37. SOUTH AFRCA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 38. REST OF LAMEA NISIN MARKET, 2020-2030 ($MILLION)
FIGURE 39. TOP WINNING STRATEGIES, BY YEAR, 2017-2021*
FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021* (%)
FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY, 2017-2021*
FIGURE 42. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 43. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 44. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45. DUPONT DE NEMOURS, INC.,: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 46. DUPONT DE NEMOURS, INC.,: NET SALES, 2018-2020 ($MILLION)
FIGURE 47. DUPONT DE NEMOURS, INC.,: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 48. DUPONT DE NEMOURS, INC,: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 49. MERCK GROUP: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 50. MERCK GROUP: NET SALES, 2018-2020 ($MILLION)
FIGURE 51. MERCK GROUP: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52. ROYAL DSM: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 53. ROYAL DSM: NET SALES, 2018-2020 ($MILLION)
FIGURE 54. ROYAL DSM: REVENUE SHARE BY SEGMENT, 2020 (%)

Companies Mentioned

  • Cayman Chemical Company
  • Chihon Biotechnology Co. Ltd.
  • Duke Thomson's India Pvt. Ltd.
  • DuPont de Nemours Inc.
  • Galactic
  • Mayasan Biotech
  • Merck Group
  • Royal DSM
  • Santa Cruz Biotechnology Inc.
  • Siveele B.V.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information